Actelion’s ambitious independent-minded CEO will drive up takeover price

Israel’s Cellcom launches app for Apple TV service
November 28, 2016
Exclusive: Chinese government money backs buyout firm’s deal for U.S. chip maker
November 28, 2016
This post was originally published on this site

ZURICH (Reuters) – Actelion Chief Executive Jean-Paul Clozel’s desire to keep Europe’s biggest biotech company independent after building it from scratch, means Johnson & Johnson will have to pay a steep premium if a takeover is to succeed.